2006Journal of Medical ForumRequires access

Transurethral Vapor-resection of Prostate in High Risk Patients with Large Volume Benign Prostate Hyperplasia

Yongchao Ge

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy and safety of transurethral vapor-resection of the prostate(TUVP) in high risk patients with large volume benign prostate hyperplasia(BPH).Methods Between October 2000 and August 2005,there were 62 patients with BPH,average age(74.5),coexist urological and systemic disease 2 kinds,mean prostate weight 50g were treated with TUVP.Patients were followed up with IPSS,QOL,PVR and urodynamic exminations.Results TUVP procedures were successful in all cases after meticulous pro-opertive preparation.The IPSS were decreased from 26.8(24~35) preoperatively to 6.8(6~14) postoperatively,MFR increased from(6.1 ml/s)(5~10ml/s) preoperatively to 18.5ml/s(15~26ml/s) postoperatively,PVR decreased from 376ml to 8.8ml(8~22ml) after fallow-up 3~36month.Conclusion TUVP is a simple,effective and safe method to treat high risk patients with large volume BPH.

About this research paper

What this paper is about

Objective To evaluate the efficacy and safety of transurethral vapor-resection of the prostate(TUVP) in high risk patients with large volume benign prostate hyperplasia(BPH).Methods Between October 2000 and August 2005,there were 62 patients with BPH,average age(74.5),coexist urological and systemic disease 2 kinds,mean prostate weight 50g were treated with TUVP.Patients were followed up with IPSS,QOL,PVR and urodynamic exminations.Results TUVP procedures were successful in all cases after meticulous pro-opertive preparation.The IPSS were decreased from 26.8(24~35) preoperatively to 6.8(6~14) postoperatively,MFR increased from(6.1 ml/s)(5~10ml/s) preoperatively to 18.5ml/s(15~26ml/s) postoperatively,PVR decreased from 376ml to 8.8ml(8~22ml) after fallow-up 3~36month.Conclusion TUVP is a simple,effective and safe method to treat high risk patients with large volume BPH.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy and safety of transurethral vapor-resection of the prostate(TUVP) in high risk patients with large volume benign prostate hyperplasia(BPH).Methods Between October 2000 and August 2005,there were 62 patients with BPH,average age(74.5),coexist urological and systemic disease 2 kinds,mean prostate weight 50g were treated with TUVP.Patients were followed up with IPSS,QOL,PVR and urodynamic exminations.Results TUVP procedures were successful in all cases after meticulous pro-opertive preparation.The IPSS were decreased from 26.8(24~35) preoperatively to 6.8(6~14) postoperatively,MFR increased from(6.1 ml/s)(5~10ml/s) preoperatively to 18.5ml/s(15~26ml/s) postoperatively,PVR decreased from 376ml to 8.8ml(8~22ml) after fallow-up 3~36month.Conclusion TUVP is a simple,effective and safe method to treat high risk patients with large volume BPH.

Key concepts: Medicine, Prostate, Hyperplasia, Urology, Transurethral resection of the prostate, Resection, Surgery, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Transurethral Vapor-resection of Prostate in High Risk Patients with Large Volume Benign Prostate Hyperplasia — Research Paper | ScholarLens